Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence

The recombinant zoster vaccine (RZV) was licensed in the US for prevention of herpes zoster (HZ) in 2017. We conducted a literature search (January 1, 2017–August 1, 2023) using PubMed, Embase, and Scopus to consolidate the real-world evidence related to RZV. Overall, RZV effectiveness against HZ wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Raunak, Singer, David, Chmielewski-Yee, Elizabeth, Dessart, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653743/
https://www.ncbi.nlm.nih.gov/pubmed/37967254
http://dx.doi.org/10.1080/21645515.2023.2263979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653743/
https://www.ncbi.nlm.nih.gov/pubmed/37967254
http://dx.doi.org/10.1080/21645515.2023.2263979

Ejemplares similares